Somatropin Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-11-14 · last update 2025-11-14
Manufacturers: Novo Nordisk, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21) | Novo Nordisk, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/14/2025 Updated 11/14/2025 Discontinued 11/14/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)